Estradiol diagnostic test kits recalled for falsely elevated results
Siemens Atellica IM Enhanced Estradiol test kits can produce falsely elevated results in plasma specimens, potentially leading to misinterpretation of patient hormone measurements. Approximately 2,044 units worldwide are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II in vitro diagnostic device recall with potential to produce inaccurate test results that could affect clinical decision-making. Although no illnesses or injuries are reported in the source, the defect presents a risk of patient harm through misinterpretation of critical hormone test measurements.
Plain-English summary
Siemens Healthcare Diagnostics is recalling the Atellica IM Enhanced Estradiol (eE2) 100T diagnostic test kits due to their potential to produce falsely elevated results when testing plasma specimens. This defect could lead clinicians to misinterpret patient results.
The affected test kits were distributed worldwide, including throughout the United States and numerous international markets in Europe, Asia, Africa, and the Middle East. All lot numbers containing the specified UDI codes are included in this recall, with approximately 2,044 units affected.
Healthcare facilities and laboratories currently using these test kits should contact Siemens Healthcare Diagnostics for replacement or return instructions. Facilities should review their procedures and consider the appropriateness of retesting patients whose results were obtained with these kits, as falsely elevated hormone measurements could impact clinical decision-making.
The recalled product
- Product
- Atellica IM Enhanced Estradiol (eE2) 100T - In vitro diagnostic use in the quantitative determination of estradiol SMN: 10995561 All lots
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Affected units
- 2,044
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · falsely elevated results
See all →- HighEstrone RIA kits give falsely increased results from a bovine albumin lot
FDA (Devices) · 2025-07-30
- HighAbbott Alinity c Hemoglobin Reagent Kit may produce falsely elevated test results
FDA (Devices) · 2022-08-03
- HighMedical Diagnostic Test Kit Issues Falsely Elevated Estradiol Results
FDA (Devices) · 2022-05-11